tiprankstipranks
Liquidia Technologies: Promising Outlook with Yutrepia Launch and Legal Wins Support Buy Rating
PremiumRatingsLiquidia Technologies: Promising Outlook with Yutrepia Launch and Legal Wins Support Buy Rating
6d ago
Buy Rating for Liquidia Technologies: Anticipated FDA Approval and Market Expansion Drive Positive Outlook
Premium
Ratings
Buy Rating for Liquidia Technologies: Anticipated FDA Approval and Market Expansion Drive Positive Outlook
6d ago
United Therapeutics price target lowered to $314 from $328 at BofA
Premium
The Fly
United Therapeutics price target lowered to $314 from $328 at BofA
6d ago
United Therapeutics price target lowered to $346 from $354 at Morgan Stanley
PremiumThe FlyUnited Therapeutics price target lowered to $346 from $354 at Morgan Stanley
26d ago
Buy Rating for Liquidia Technologies Driven by Yutrepia’s Unique Technology and Favorable Legal Outcomes
Premium
Ratings
Buy Rating for Liquidia Technologies Driven by Yutrepia’s Unique Technology and Favorable Legal Outcomes
2M ago
Liquidia named a top pick for 2025 at Needham
Premium
The Fly
Liquidia named a top pick for 2025 at Needham
3M ago
Liquidia management to meet virtually with BTIG
PremiumThe FlyLiquidia management to meet virtually with BTIG
4M ago
Liquidia Corporation’s Q3 2024 Financial Highlights
Premium
Company Announcements
Liquidia Corporation’s Q3 2024 Financial Highlights
4M ago
Liquidia reports Q3 EPS (30c), consensus (37c)
Premium
The Fly
Liquidia reports Q3 EPS (30c), consensus (37c)
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100